Skip to main content
. Author manuscript; available in PMC: 2012 Nov 25.
Published in final edited form as: J Thorac Oncol. 2010 Jun;5(6):810–817. doi: 10.1097/jto.0b013e3181d89f95

Table 4.

Cox model for disease-free survival (DFS) and overall survival (OS) statistics of the molecular biologic markers

Marker p-value from Wald test for DFS
HR (95% CI) *
single marker multiple markers (Model 5)
bcl-2
(positive vs. negative)
(Model 1)
0.4812 0.3382
0.81 (0.45, 1.46) 0.79 (0.51, 1.24)

p53
(positive vs. negative)
(Model 2)
0.0385 0.0029
1.56 (1.02, 2.37) 1.95 (1.26, 3.02)

Blood group antigen A
(presence vs. absence)
(Model 3)
0.6111 0.7463
0.88 (0.55, 1.43) 0.92 (0.55, 1.54)

Mucin
(positive vs. negative)
(Model 4)
0.0021 0.0018
1.88 (1.26, 2.81) 2.05 (1.31, 3.21)

p-value from Wald test for OS
HR (95% CI) *
Marker single marker multiple markers (Model 5)

bcl-2
(positive vs. negative)
(Model 1)
0.1017 0.1022
0.57 (0.29, 1.12) 0.54 (0.26, 1.13)

p53
(positive vs. negative)
(Model 2)
0.0190 0.0005
1.71 (1.09, 2.67) 2.30 (1.44, 3.68)

Blood group antigen A
(presence vs. absence)
(Model 3)
0.9199 0.7981
0.98 (0.59, 1.61) 0.93 (0.55, 1.60)

Mucin
(positive vs. negative)
(Model 4)
0.0040 0.0037
1.88 (1.22, 2.89) 2.03 (1.26, 3.26)
*

Hazard ratio and its 95% confidence interval.